Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Halfpenny Technologies was a private healthcare IT company focused on interoperability, health information exchange, computerized physician order entry, and clinical data exchange for providers, laboratories, hospitals, pharmacies, and health plans. Its core offerings were secure, cloud-based, vendor-neutral connectivity and business intelligence solutions that enabled the exchange of laboratory, imaging, medical record, and related clinical data across disparate healthcare systems. The company was founded in 2000 in Pennsylvania and built a reputation in laboratory integration and provider connectivity. In June 2019, Halfpenny Technologies was acquired by Accumen, and its interoperability assets were later integrated into AccumenConnect and subsequently hc1 InterConnect. It was not a drug-development biotech company, but rather a commercial healthcare technology company serving diagnostic and care coordination workflows.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Halfpenny Technologies.